Authors


Yvonne Ou, MD

Latest:

Lifestyle modifications for glaucoma with Yvonne Ou, MD

Yvonne Ou, MD, a professor of ophthalmology at the University of California San Francisco, spoke about lifestyle modifications for glaucoma at this year's Glaucoma 360 meeting.


Xiaoming Liu, PhD

Latest:

Novel multistage model enhances OCT GA segmentation

Researchers introduce a multistage dual-branch network to improve accuracy and efficiency


Lilia Dumbraveanu, MD, PhD

Latest:

Study examines efficiency of physiotherapy in treating, preventing uncomplicated acquired myopia

Research explores innovative physiotherapeutic approaches to managing myopia progression, showing promising results in slowing its advancement over two years.


Peg Achenbach, OD, FAAO

Latest:

Glaucoma 360: ‘Innovation is marching on’

Adrienne Graves, PhD, and Andrew Iwach, MD, co-founders of Glaucoma 360, highlight the 13th annual Glaucoma 360 New Horizons Forum, held this year at the Westin St. Francis San Francisco on Union Square.


Katrina Ronne

Latest:

Breaking barriers: Australian Society of Ophthalmologists’ first woman CEO steps up

Katrina Ronne shares her vision to empower ophthalmologists, champion equity, and strengthen advocacy for better eye health outcomes across Australia.


John A. Hovanesian, MD

Latest:

Pearls to enhance patient comfort and streamline cataract surgery

Physicians should consider the roles of verbal and ocular anesthesia.


Olivia J. Killeen, MD

Latest:

Anterior segment ischemia following three-muscle strabismus surgery

Case of anterior segment ischemia involves young adult with prior carotid artery injury.


Aaishwariya Gulani

Latest:

Advocacy in Ophthalmology

Discover how advocacy can impact your clinical work and ultimately patient care.


Bria George, PharmD

Latest:

Dropless cataract surgery: Shifting paradigm in postoperative care

Removing drops from procedure increases adherence and comfort for most patients.


Carolyn Majcher, OD, FAAO

Latest:

Unlocking geographic atrophy

Staging AMD accurately and identifying clinical features that are linked with disease progression are key.


S. Barry Eiden, OD, FAAO

Latest:

International Keratoconus Academy continues to provide cutting-edge education

Over the years, IKA has become an invaluable resource for eye care professionals.


Ehsan Sadri, MD, FACS

Latest:

(Part 2) From ophthalmology’s lockdown to lasting change: The pandemic habits that stuck

From revised patient flow to smarter tech adoption, ophthalmologists share which changes from 2020 have become cornerstones of modern care—and how they’re preparing for the next big disruption


Matthew Roe, MD, MHS

Latest:

Big data drives opportunity for real-world evidence

Evidence-based medicine can lead to personalized care, better results for patients


Dain B. Brooks, MD

Latest:

Surgical options for normalizing neuroadaptation in patients

Technical details, communication style key to presbyopia-correcting IOL journey.


Alon Kahana, MD, PhD

Latest:

Pearls for the treatment of patients with neurotrophic keratitis

Optimizing corneal neurotization outcomes with cryopreserved amniotic membrane.


Andrew D. Pucker, OD, PhD, FAAO

Latest:

The future of decentralized clinical trials in ophthalmology

Research can drive opportunities for patients with rare diseases


W. Lloyd Clark, MD

Latest:

ACHIEVING IMPROVED OUTCOMES THROUGH PARTNERSHIPS BETWEEN OPTOMETRISTS AND RETINA SPECIALISTS

Considerations in the treatment of diabetic retinopathy and diabetic macular edema.


Fatema Ghasia, MD

Latest:

AI and eye tracking: Technological companions to assess amblyopia in pediatric patients

These tools help fill a gap that current technologies cannot achieve as effectively.


Kenneth A. Beckman, MD, FACS

Latest:

World Cornea Congress IX: Epi-on and accelerated crosslinking with Kenneth Beckman, MD

Epi-on corneal crosslinking is advancing through innovations like supplemental oxygen, chemical oxygenation, and laser-assisted techniques.


Grazia Pertile, MD

Latest:

Retinal detachments: managing retinal folds, role of anterior vitreous

Grazia Pertile, MD, discusses the highlights of her presentations on the management of retinal folds after retinal detachment and the role of the anterior vitreous as a cause of recurrent retinal detachment.


Larissa Camejo, MD

Latest:

MicroPulse TLT offers proven versatility in the practice

Ophthalmologist offers pearls for use of technology in daily work.


Shigeru Kinoshita, MD, PhD

Latest:

Innovation and the clinician-scientist

A discussion with Shigeru Kinoshita, MD, PhD; and Edward J. Holland, MD.


Scott D. Walter, MD, MSc, FASRS

Latest:

Final Thoughts on Case Presentations and Advanced Therapies

Retinal specialists conclude their discussion with key highlights from each patient case of retinal vascular disease and pearls the audience can apply in their practice.


Panayiota Founti, PhD, FEBO

Latest:

Patient glaucoma management focuses on pivotal studies

Randomly assigned controlled trials key in increasing understanding of disease.


Eva Kim, MD

Latest:

Envision Summit 2025: Looking forward to upcoming sessions

Laxmi Devisetty, MD, and Eva Kim, MD, look ahead at upcoming sessions focusing on geographic atrophy and refractive and cataract surgery at the Envision Summit 2025.


Sara Wester, MD

Latest:

Envision Summit 2025: Women leaders in eye health

At the Envision Summit 2025 in San Juan, Puerto Rico, Sara Wester, MD, discussed the Women Leaders in Eye Health session at the conference and the donation from Orbis that supported the session.


Thomas W. Samuelson, MD

Latest:

Thomas W. Samuelson, MD, shares clinical perspectives on DSLT, SLT, and glaucoma management

Direct selective laser trabeculoplasty enhances the experience for both patients and physicians, he notes, while also mitigating issues related to poor adherence and ocular surface disease from topical therapy.


Wendy Lee, MD

Latest:

EnVision Summit 2025: Wendy Lee, MD, highlights evolving trends in oculoplastics and aesthetics in program

Wendy Lee, MD, an oculoplastics specialist and member of the program committee at EnVision Summit, shares an agenda that will include a mix of functional oculoplastics, aesthetics, and live facial rejuvenation demonstrations at the upcoming event, which will be held from February 14 to 17, 2025, at the Caribe Hilton San Juan in Puerto Rico.


Paul Badawi

Latest:

What’s Your WhEYE? A conversation with Paul Badawi, CEO of Sight Sciences

Paul Badawi, co-founder and CEO of Sight Sciences, sits down with host Neda Shamie, MD, to discuss his journey into the field of eye care, what motivates him, the transformative approach to glaucoma patient care, and the spark that led him and his ophthalmologist brother, David Badawi, MD, to start the company together.


Joel S. Schuman, MD

Latest:

Should we always trust the OCT?

There are times when physicians should be critical of scans.

© 2025 MJH Life Sciences

All rights reserved.